The Cancer Proteomics Core
The mission of the DF/HCC Cancer Proteomics Core is to provide comprehensive interdisciplinary, translationally and clinically oriented facilities for high sensitivity, high resolution and high throughput proteomics, with particular emphasis on clinical sample analysis and in depth proteomic consultation.
The Cancer Proteomics Core (CPC) as a DF/HCC shared resource was established in July 2004, following a call from DF/HCC members for access to mass spectrometry services. This Core was officially approved as a result of discussions at several meetings of the DF/HCC Executive Committee. The Core is integrated into the existing infrastructure and complementary facilities of the BIDMC Genomics Center, located in BIDMC space on the second floor of the Harvard Institutes of Medicine and on the tenth floor of the Harvard New Research Building. Although designated as a DF/HCC Core only in July 2004, its scientific staff has provided support to more than 60 different DF/HCC investigators from various Harvard institutions on basic and clinical aspects of cancer. The Core director and its highly experienced staff have ample prior experience to administer a core and a well-established history of interactions with investigators from all Harvard affiliated institutions and beyond. The Proteomics Core is already supporting several large scale DF/HCC projects on proteomic profiling of clinical samples and protein identification.